Ottawa, Ontario--(Newsfile Corp. - April 24, 2024) - Avivagen Inc. (TSXV: VIV) ("Avivagen" or the "Company"), a life sciences corporation focused on developing and commercializing products for livestock,...
Avivagen Inc. (TSXV:VIV) (“Avivagen”, the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that...
Monday U.S. Economic Lookahead Chicago Fed national activity index (Aug.) Featured ...
Has announced its unaudited financial results for the third quarter of 2022. The Company reported net ...
Has secured a promising new customer in the Mexican dairy industry. The agreement will see the customer ...
LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / Avivagen: (TSXV:VIV)(OTCQB:VIVXF), a life sciences company with a natural, approved and patented alternative to antibiotics, today announced that it will...